| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 14.13B | — |
| Operating expense | — | — |
| Net income | 6.10B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CVG.F returned +31.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +44.7% |
| 1 year | +31.0% |
| 5 years | +407.8% |
| 10 years | +1925.0% |
| All-time high | €1.37 (May 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in CVG.F would be worth today ›Yes. CSPC Pharmaceutical Group Limited paid 2 dividends over the past 12 months. The most recent was €0.02 per share on Jun 24, 2026. The dividend yield is 3.96%.
CSPC Pharmaceutical Group Limited is part of the Healthcare sector.
CSPC Pharmaceutical Group Limited has a market cap of 11.98B EUR, based on the latest quote.
CSPC Pharmaceutical Group Limited is expected to report earnings around Nov 19, 2026. That date is an estimate and has not been confirmed by the company.